A recent report published by Infinium Global Research on insulin delivery system market provides in-depth analysis of segments and sub-segments in the global as well as regional insulin delivery system market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional insulin delivery system market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global insulin delivery system market. According to the report, the insulin delivery system market was worth USD 9724.4 million in 2016 and it is expected to reach USD 14537 million by 2024. The global insulin delivery system market is projected to grow at a CAGR of 5.02% over the forecast period of 2018-2024.

Market Insight

Patient is moving from hospitals to specialty clinics, users prefer syringes and insulin pens because of their low cost, refining policies for compensation, and availability, affordability of devices, are some of the key factor driving the growth of global insulin delivery system market moreover, needle nervousness in patients affect the growth of the pen needles and syringes market, problems related with the reuse of pen needles and infusion sets are the key factors restraining the growth of this market. Growing research and development, increasing expenditure in emerging economies on diabetes-related health are likely to bring more opportunities to this market.

Geographically, the market is divided into the Americas, Europe, APAC and RoW. The U.S is a key country that is driving the North America insulin delivery system market. The APAC region is expected to grow at the fastest CAGR over the forecast period. India and China are known as the diabetes capital of the world. Both countries are among the top 3 countries with a high number of the diabetic population. Going further, government initiatives in healthcare policies and rising disposable income are among the vital factors that would lead to the adoption of the insulin delivery system market in the Asia-Pacific region.

Segment Covered

The report on global insulin delivery system market covers segments such as product type, and end user. On the basis of product type, the sub-markets include insulin pens, Insulin jet injectors, syringes, and insulin pumps. On the basis of end user, the sub-markets include specialty diabetic clinics, hospitals, and retail Channels.

Companies Profiled:

The report provides profiles of the companies in the market such as Eli Lilly and Company, Ypsomed Holding AG, Becton, Dickinson and Company, Novo Nordisk A/S, Tandem Diabetes Care, Inc., Medtronic PLC, Sanofi, Animas Corporation (Johnson and Johnson), Insulet Corporation, and Biocon Limited.

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of insulin delivery system market. Moreover, the study highlights current market trends and provides forecast from 2018-2024. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.